NOVATIM is an innovative biotechnology company committed to developing novel tumor immune-therapeutics through its own pioneer technology platform and affording drugs for unmet clinical needs
NOVATIM is an innovative biotechnology company committed to developing novel tumor immune-therapeutics through its own pioneer technology platform and affording drugs for unmet clinical needs
吴国祥博士
科弈药业创始人、董事长兼CEO
公司成立于
FIC/BIC产品
完成首轮融资
我们聚焦于肿瘤免疫治疗，为全球患者带来新的希望
